You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Tissue Factor Antagonists for ALI/ARDS
SBC: Altor BioScience, LLC Topic: N/ADESCRIPTION (provided by applicant): The objective of this project is to develop an anti-tissue factor antibody, Sunol-cH36, as a treatment for Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS). The association between coagulation and inflammation has been well established and a central role in the coagulopathy of ALI/ARDS has been attributed to tissue factor (TF). TF binding ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Transgenic Plant Technology for Producing Therapeutic Recombinant Antibodies
SBC: Altor BioScience, LLC Topic: N/ADESCRIPTION (provided by applicant): The need to develop novel, cost effective manufacturing processes to produce therapeutic antibodies commercially will continue to be of considerable and growing interest to biopharmaceutical and medical industries. The long-term objectives related to this application are to develop novel manufacturing processes using stable transgenic plants, namely Arabidop ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
NOVEL DRUG DISCOVERY FOR RHEUMATOID ARTHRITIS
SBC: Altor BioScience, LLC Topic: N/ADESCRIPTION (provided by applicant): The long-term objective of this project is to develop small molecule inhibitors of MHC class II activity for the treatment of rheumatoid arthritis (RA). The strong genetic association between specific MHC class II alleles, such as HLA-DR molecules containing the shared epitope, and susceptibility to RA provides support to a mechanism in which disease-associate ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Chimeric CD80-SA as a Novel Cancer Vaccine
SBC: APOIMMUNE, INC Topic: N/ADESCRIPTION (provided by applicant): Cancer is one of the major causes of death in the U.S. and many developed countries with an estimated economic burden of over 100 billion dollars in direct and indirect costs in the U.S. alone. Although surgery, chemotherapy, and radiotherapy are commonly used treatment modalities, these therapies not only fail to effectively manage cancer, but also are associ ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
MicroArrays in Grass Shrimp and Sheepshead Minnows
SBC: EcoArray, Inc. Topic: N/ADESCRIPTION (provided by applicant): Microarrays are a powerful way to measure the impact of contaminants present in the environment. In this proposal, we will sequence genes from grass shrimp and sheepshead minnows, make trial microarrays from these genes, and show the expression patterns that result from exposure to contaminants that are present in the environment. Measurement and analysis of c ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
SIMULATIONS FOR DRUG RELATED SCIENCE EDUCATION
SBC: ARCHIE MD INC. Topic: N/AN/A
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Novel Biomarkers for Stroke Injury
SBC: BANYAN BIOMARKERS, INC. Topic: N/AStroke is the second leading cause of death worldwide and the primary cause of serious, long-term disability and nursing home admissions. The absence of clinically useful diagnostics has severely impeded effective management and treatment of acute ischemic stroke. Currently available diagnostics are either expensive and/or unreliable and there are no simple, rapid, non-invasive tests to diagnose a ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Cord Blood: Treatment for Acute Myocardial Infarction
SBC: SANERON CCEL THERAPEUTICS, INC. Topic: N/ADESCRIPTION (provided by applicant): Transplantation of human umbilical cord stem cells (hUCBC) has been shown to be effective in limiting infarct size and in the preservation of left ventricular function and anatomy in a rat model. These effects have been present in studies both utilizing and not utilizing immunosuppression. Whether immunosuppression will be required in a large animal model is un ...
STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Hemorrhagic Brain Injury Repair with Human Cord Blood
SBC: SANERON CCEL THERAPEUTICS, INC. Topic: N/ADESCRIPTION (provided by applicant): Human umbilical cord blood (hUCB) is a rich source of stem cells that exhibit multipotent properties. Previous studies have shown that hUCB cells can differentiate into neural cells under the appropriate environment conditions. SANERON CCEL, Inc. is focusing on the use of hUCB as a therapeutic approach for treating a variety of neurological disorders. In this P ...
STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Kinematic Biofeedback for Independent Motor Retraining
SBC: CUSTOMKYNETICS, INC. Topic: N/ADESCRIPTION (provided by applicant): This project proposes to develop a device that will improve the quality and availability of motor retraining for individuals with neuromotor disorders due to stroke or incomplete spinal cord injury. Biofeedback of postural control variables such as ground reaction force and center of pressure sway has been used effectively, however, existing devices are not sui ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health